Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by National Cheng-Kung University Hospital.
Recruitment status was  Recruiting
Information provided by:
National Cheng-Kung University Hospital Identifier:
First received: May 15, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)